Krystallia Pantiri is a Research Consultant in the Rotterdam office, the Netherlands. Krystallia works within the Strategic Market Access and Patient-Centered Outcomes Centers of Excellence. Her all-round experience includes (systematic) literature reviews to inform network meta-analyses, global value dossiers and HTA/ reimbursement dossiers, patient/stakeholder engagement, preference studies and qualitative patient reported outcomes (PRO) research. Disease areas she has worked in include vaccines, inflammatory disease, respiratory diseases, oncology, hematology, neurological disorders and orphan diseases.
Krystallia has extensive experience with reviews of epidemiology, disease burden and treatment patterns, using the results as input for landscape analyses, strategic advice and value story development. She has been working on international projects involving development and validation of PRO instruments and analysis of quantitative and qualitative data. In this context, she performs literature reviews, coordinates patient and clinician research and writes corresponding protocols, reports and publications for peer-reviewed journals. She has presented work at international conferences including ISPOR and ISOQOL. Krystallia joined Pharmerit in 2013 with a Master degree in Health Economics, Policy and Law (Erasmus University Rotterdam, the Netherlands).